Drzezga AE - Search Results

1

Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.

Granert O, Drzezga AE, Boecker H, Perneczky R, Kurz A, Götz J, van Eimeren T, Häussermann P. Granert O, et al. Among authors: drzezga ae. J Nucl Med. 2015 Dec;56(12):1916-21. doi: 10.2967/jnumed.115.156067. Epub 2015 Sep 17. J Nucl Med. 2015. PMID: 26383147 Free article.

2

18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, Römer W, Tatsch K, Weber W, Bartenstein P. Drzezga A, et al. J Nucl Med. 1999 May;40(5):737-46. J Nucl Med. 1999. PMID: 10319744 Free article.

3

Lasting cortical activation after repetitive TMS of the motor cortex: a glucose metabolic study.

Siebner HR, Peller M, Willoch F, Minoshima S, Boecker H, Auer C, Drzezga A, Conrad B, Bartenstein P. Siebner HR, et al. Neurology. 2000 Feb 22;54(4):956-63. doi: 10.1212/wnl.54.4.956. Neurology. 2000. PMID: 10690992

4

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M. Ishii K, et al. J Nucl Med. 2001 Apr;42(4):548-57. J Nucl Med. 2001. PMID: 11337540 Free article.

5

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF. Lautenschlager NT, et al. Dement Geriatr Cogn Disord. 2001 Nov-Dec;12(6):379-86. doi: 10.1159/000051284. Dement Geriatr Cogn Disord. 2001. PMID: 11598309

6

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A. Riemenschneider M, et al. Neurology. 2002 Jun 11;58(11):1622-8. doi: 10.1212/wnl.58.11.1622. Neurology. 2002. PMID: 12058089

7

Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia.

Drzezga A, Grimmer T, Siebner H, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. J Neurol. 2002 Sep;249(9):1263-7. doi: 10.1007/s00415-002-0832-z. J Neurol. 2002. PMID: 12242551

8

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Riemenschneider M, et al. Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729. Arch Neurol. 2002. PMID: 12433260

9

The role of biological markers in the early and differential diagnosis of Alzheimer's disease.

Kurz A, Riemenschneider M, Drzezga A, Lautenschlager N. Kurz A, et al. J Neural Transm Suppl. 2002;(62):127-33. doi: 10.1007/978-3-7091-6139-5_13. J Neural Transm Suppl. 2002. PMID: 12456058 Review.

10

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A. Drzezga A, et al. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. doi: 10.1007/s00259-003-1194-1. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764551 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters